<?xml version="1.0" encoding="UTF-8"?>
<p>Many transcripts show hundreds of genes change in expression in melanoma progression. These changes involve genetic and epigenetic mechanisms, such as mutations, gene silencing of tumor suppressors through DNA methylation in promoter regions, oncogene activation, chromatin remodeling, and regulation mediated by non-coding RNAs, such as microRNAs (miRNAs) through their regulation of genes involved in different cellular processes such as proliferation, death, cycle control, senescence, angiogenesis, differentiation, and even metastasis [
 <xref rid="B1-ijms-22-01591" ref-type="bibr">1</xref>,
 <xref rid="B2-ijms-22-01591" ref-type="bibr">2</xref>,
 <xref rid="B3-ijms-22-01591" ref-type="bibr">3</xref>,
 <xref rid="B4-ijms-22-01591" ref-type="bibr">4</xref>,
 <xref rid="B5-ijms-22-01591" ref-type="bibr">5</xref>,
 <xref rid="B6-ijms-22-01591" ref-type="bibr">6</xref>,
 <xref rid="B7-ijms-22-01591" ref-type="bibr">7</xref>,
 <xref rid="B8-ijms-22-01591" ref-type="bibr">8</xref>]. miRNA can have hundreds of mRNAs as molecular targets. One mRNA can target several miRNAs, and the researchers will identify variations in the expression of thousands of genes that may result from changes in some miRNAsâ€™ expression patterns [
 <xref rid="B9-ijms-22-01591" ref-type="bibr">9</xref>,
 <xref rid="B10-ijms-22-01591" ref-type="bibr">10</xref>,
 <xref rid="B11-ijms-22-01591" ref-type="bibr">11</xref>,
 <xref rid="B12-ijms-22-01591" ref-type="bibr">12</xref>,
 <xref rid="B13-ijms-22-01591" ref-type="bibr">13</xref>].
</p>
